GAMMA Investing’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

GAMMA Investing’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-128	Closed	-$4.27K	–	3861
2024 Q3	$4.27K	Hold	128	–	–	﹤0.01%	2809
2024 Q2	$3.46K	Buy	128 +56	+78%	+$1.1K	﹤0.01%	2698
2024 Q1	$1.55K	Buy	+72	New	+$1.57K	﹤0.01%	2827

GAMMA Investing's LBPH Position: Q4 2024 in Review

GAMMA Investing sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 128 shares — an estimated $4.27K sold.

GAMMA Investing first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $4.27K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

GAMMA Investing reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
GAMMA Investing sold 128 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $4.27K.
GAMMA Investing first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
GAMMA Investing's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $4.27K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.